These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15543197)

  • 1. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
    Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced in vivo motility of human umbilical cord blood hematopoietic stem/progenitor cells introduced via intra-bone marrow injection into xenotransplanted NOD/SCID mouse.
    Gao J; Li Y; Lu S; Wang M; Yang Z; Yan X; Zheng Y
    Exp Hematol; 2009 Aug; 37(8):990-7. PubMed ID: 19481136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
    Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
    Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential.
    Zheng Y; Watanabe N; Nagamura-Inoue T; Igura K; Nagayama H; Tojo A; Tanosaki R; Takaue Y; Okamoto S; Takahashi TA
    Exp Hematol; 2003 Dec; 31(12):1237-46. PubMed ID: 14662330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice.
    Wulf-Goldenberg A; Eckert K; Fichtner I
    Eur J Cell Biol; 2008 Feb; 87(2):69-80. PubMed ID: 17931741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
    Noort WA; Wilpshaar J; Hertogh CD; Rad M; Lurvink EG; van Luxemburg-Heijs SA; Zwinderman K; Verwey RA; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
    Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
    Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem and/or progenitor cells in a nonobese diabetic/Shi-SCID mice serial xenotransplantation model and immune cell activities in vitro: a comparative study of the filter method and the hydroxyethyl starch method.
    Yasutake M; Zheng Y; Inoue-Nagamura T; Akagawa E; Tokushima Y; Terashima S; Takahashi TA
    Transfusion; 2005 Dec; 45(12):1899-908. PubMed ID: 16371042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the immature characteristics of umbilical cord blood-derived mesenchymal stem cells and engraftment of hematopoietic stem cells in NOD/SCID mice.
    Yim YS; Noh YH; Kim DH; Lee MW; Cheuh HW; Lee SH; Yoo KH; Jung HL; Sung KW; Choi SJ; Oh WI; Yang YS; Koo HH
    Transplant Proc; 2010 Sep; 42(7):2753-8. PubMed ID: 20832581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study.
    Berger M; Frairia R; Piacibello W; Sanavio F; Palmero A; Venturi C; Pignochino Y; Berta L; Madon E; Aglietta M; Fagioli F
    Exp Hematol; 2005 Nov; 33(11):1371-87. PubMed ID: 16263422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.